Tuberc Respir Dis.  2017 Apr;80(2):210-211. 10.4046/trd.2017.80.2.210.

Cutaneous Leukocytoclastic Vasculitis with Gastrointestinal Involvement after Anti-Tuberculosis Treatment

• Shim S
• Jung CY

• KMID: 2375991
• DOI: http://doi.org/10.4046/trd.2017.80.2.210

Abstract

No abstract available.

MeSH Terms

Vasculitis, Leukocytoclastic, Cutaneous*

Figure

• 

  Figure 1 Patient photographs showing the pruritic patches, macules, and papules in both legs extended to the trunk and both arms after 2 weeks of anti-tuberculosis treatment.

• 

  Figure 2 Esophagogastroduodenoscopy of patient showing multiple flat erythematous and hemorrhagic changes in the duodenum at diagnosis (A) and vascular infiltration of neutrophils and hemorrhage in the antrum of the stomach (B) (H&E stain, ×100).

Reference

1. Carlson JA, Ng BT, Chen KR. Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am J Dermatopathol. 2005; 27:504–528.

2. Avcu G, Sensoy G, Celiksoy MH, Sogut A, Kefeli M, Karli A, et al. Cutaneous leukocytoclastic vasculitis associated with anti-tuberculosis drugs. Pediatr Int. 2015; 57:155–157.

3. Kim JH, Moon JI, Kim JE, Choi GS, Park HS, Ye YM, et al. Cutaneous leukocytoclastic vasculitis due to anti-tuberculosis medications, rifampin and pyrazinamide. Allergy Asthma Immunol Res. 2010; 2:55–58.

4. Calabrese LH, Michel BA, Bloch DA, Arend WP, Edworthy SM, Fauci AS, et al. The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum. 1990; 33:1108–1113.

5. Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006; 65:936–941.